Ariz. Admin. Code § R9-6-206
A. The Department shall notify each local health agency of the format to be used by:
C. Except as specified in Table 2.4 and Article 3, a local health agency shall provide to the Department the information contained in each report of a case, suspect case, or occurrence received by the local health agency under R9-6-202 or R9-6-203, including any report of disease in a nonresident of the jurisdiction who is or has been diagnosed or treated in the jurisdiction, within five working days after receipt and shall specify:
1. Which of the following best describes the individual identified in each report:
D. Except as specified in Table 2.4 and Article 3, a local health agency shall submit to the Department a report, in a Department-provided format, of an epidemiologic investigation conducted by the local health agency:
1. In response to a report of a case, suspect case, or occurrence:
4. Including in the report of the epidemiologic investigation:
a. The information described in:
E. For each instance when the local health agency receives a report or reports indicating an outbreak or possible outbreak, the local health agency shall:
1. Within 24 hours after receiving the report or reports, provide to the Department, in a Department-provided format, the following information:
2. Within 30 calendar days after receiving the last report or reports associated with the outbreak, submit to the Department a report, in a Department-provided format, of the epidemiologic investigation conducted by the local health agency in response to the outbreak or possible outbreak, including:
New Table 4 made by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2). Table 4 repealed by final rulemaking at 23 A.A.R. 2605, effective January 1, 2018 (Supp. 17-3).
| O | Amebiasis | 🖳,→ | Giardiasis | 🗲,→,↖ | Rabies in a human |
| 🖳,→ | Anaplasmosis | !,→,↖ | Glanders | !,→ | Relapsing fever (borreliosis) |
| 🗲,→,↖ | Anthrax | 🖳 | Gonorrhea | O | Respiratory disease |
| 🖳,→ | Arboviral infection | !,→ | Haemophilus influenzae, invasive disease | !,→,↖ | Rubella (German measles) |
| 🖳,→ | Babesiosis | 🖳,→ | Hansen’s disease (Leprosy) | 🗲,→,↖ | Rubella syndrome, congenital |
| 🖳,→ | Basidiobolomycosis | !,→ | Hantavirus infection | !,→ | Salmonellosis |
| 🖳,→ | Blastomycosis | !,→ | Hemolytic uremic syndrome | !,→ | Severe acute respiratory syndrome (SARS) |
| 🗲,→,↖ | Botulism | !,→ | Hepatitis A | !,→ | Shigellosis |
| 🖳,→,↖ | Brucellosis | 🖳,→ | Hepatitis B and Hepatitis D | 🗲,→,↖ | Smallpox |
| 🖳,→ | Campylobacteriosis | 🖳 | Hepatitis C | !,→ | Spotted fever rickettsiosis (e.g., Rocky Mountain spotted fever) |
| !,→,↖ | Candida auris | 🖳,→ | Hepatitis E | 🖳 | Streptococcal group A infection, invasive disease |
| 🖳,→,↖ | Carbapenem-resistant Acinetobacter baumannii (CRAB) | 🖳,→ | HIV infection and related disease | 🖳 | Streptococcal group B infection in an infant younger than 90 days of age, invasive disease |
| 🖳,→,↖ | Carbapenem-resistant Enterobacterales (CRE) | !,→ | Influenza-associated mortality in a child | 🖳 | Streptococcus pneumoniae infection, (pneumococcal invasive disease) |
| 🖳,→,↖ | Carbapenem-resistant Pseudomonas aeruginosa (CRPA) | !,→ | Legionellosis (Legionnaires’ disease) | 🖳,→ | Syphilis |
| 🖳,→ | Chagas infection and related disease (American Trypanosomiasis) | !,→ | Leptospirosis | 🖳,→ | Taeniasis |
| 🖳,→ | Chancroid (Haemophilus ducreyi) | !,→,↖ | Listeriosis | 🖳,→ | Tetanus |
| 🖳,→ | Chikungunya | 🖳,→ | Lyme disease | 🖳,→ | Toxic shock syndrome |
| 🖳 | Chlamydia trachomatis infection | !,→ | Lymphocytic choriomeningitis | !,→ | Trichinosis |
| !,→ | Cholera | 🖳,→ | Malaria | !,→,↖ | Tuberculosis, active disease |
| 🖳 | Coccidioidomycosis (Valley Fever) | 🗲,→,↖ | Measles (rubeola) | !,→ | Tuberculosis latent infection in a child five years of age or younger |
| 🖳,→ | Colorado tick fever | !,→,↖ | Melioidosis | 🗲,→,↖ | Tularemia |
| 🖳,→ | Creutzfeldt-Jakob disease | 🗲,→,↖ | Meningococcal invasive disease | ||
| 🗲,→ | Cronobacter infection in an infant | !,→ | Middle East respiratory syndrome (MERS) | !,→ | Typhoid fever |
| 🖳,→ | Cryptosporidiosis | 🖳,→ | Mpox | !,→ | Typhus fever |
| 🖳,→ | Cyclospora infection | !,→,↖ | Mumps | !,→ | Vaccinia-related adverse event |
| 🖳,→ | Cysticercosis | 🖳 | Mycoplasma genitalium infection | !,→,↖ | Vancomycin-resistant or Vancomycin-intermediate Staphylococcus aureus |
| !,→ | Dengue | 🗲,→ | Novel coronavirus infection | 🖳,→1 | Varicella (chickenpox) |
| 🗲,→ | Diphtheria | 🗲 | Novel influenza virus infection | !,→ | Vibrio infection |
| 🖳,→ | Ehrlichiosis | !,→ | Pertussis (whooping cough) | 🗲,→,↖ | Viral hemorrhagic fever |
| 🗲,→ | Emerging or exotic disease | 🗲,→,↖ | Plague | 🖳,→ | West Nile virus infection |
| 🗲,→ | Encephalitis, parasitic | 🗲,→,↖ | Poliomyelitis (paralytic or non-paralytic) | 🗲,→,↖ | Yellow fever |
| !,→ | Encephalitis, viral | 🖳,→ | Psittacosis (ornithosis) | !,→,↖ | Yersiniosis (enteropathogenic Yersinia) |
| !,→ | Escherichia coli, Shiga toxin-producing | !,→ | Q Fever | !,→,↖ | Zika virus infection |
Key:
🗲 Notify the Department within 24 hours after receiving a report under R9-6-202 or R9-6-203.
! Notify the Department within one working day after receiving a report under R9-6-202 or R9-6-203.
🖳 Notify the Department within five working days after receiving a report under R9-6-202 or R9-6-203.
O Notify the Department within 24 hours after receiving a report or reports indicating an outbreak or possible outbreak.
→ Submit an epidemiologic investigation report within 30 calendar days after receiving a report under R9-6-202 or R9-6-203 or notification by the Department.
↖ In consultation with the Department, ensure that an isolate of the organism for each positive culture, if available, or a specimen for each positive test result is submitted to the Arizona State Laboratory within one working day.
Footnote:
1 Submit an epidemiologic investigation report only if a case or suspect case has died as a result of the communicable disease.
New Table 2.4 made by final rulemaking at 23 A.A.R. 2605, effective January 1, 2018 (Supp. 17-3). Amended by final rulemaking at 31 A.A.R. 1317 (April 25, 2025), effective June 2, 2025 (Supp. 25-2).
Section renumbered from R9-6-203 and amended by final rulemaking at 10 A.A.R. 3559, effective October 2, 2004 (Supp. 04-3). Amended by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2). Amended by final rulemaking at 23 A.A.R. 2605, effective January 1, 2018 (Supp. 17-3).